Education
About Us
Working with TipRanks
Follow Us
Rita J. Balice-Gordon Insider Profile
4 Followers
Rita J. Balice-Gordon, Director at Collegium Pharmaceutical, holds 52.63K shares in Collegium Pharmaceutical (Ticker: COLL). Most recently, Rita J. Balice-Gordon Sold 3,650 shares of Collegium Pharmaceutical on Dec 09, 2025 for an estimated value of $171.66K.
Rita J. Balice-Gordon has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Rita J. Balice-Gordon's holdings
Insider Roles
Director
Roles that Rita J. Balice-Gordon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rita J. Balice-Gordon
Rita J. Balice-Gordon's Trading History
List of latest transactions for each holding click on a transaction to see Rita J. Balice-Gordon's performance on stock
You May Also Like
Rita J. Balice-Gordon insider profile FAQ
What is the percentage of profitable transactions made by Rita J. Balice-Gordon?
The percentage of profitable transactions made by Rita J. Balice-Gordon is ―.
What is the average return per transaction made by Rita J. Balice-Gordon?
The average return per transaction made by Rita J. Balice-Gordon is ―.
What stocks does Rita J. Balice-Gordon hold?
Rita J. Balice-Gordon holds: COLL stocks.
What was Rita J. Balice-Gordon’s latest transaction?
Rita J. Balice-Gordon latest transaction was an Informative Sell of $171.66K.
What was Rita J. Balice-Gordon's most profitable transaction?
Rita J. Balice-Gordon’s most profitable transaction was an Informative Sell of COLL stock on December 9, 2025. The return on the trade was -3.90%.
What is Rita J. Balice-Gordon's role in Collegium Pharmaceutical?
Rita J. Balice-Gordon's role in Collegium Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.